Baird Medical Investment Holdings Ltd, a leader in minimally invasive Microwave Ablation (MWA) technology, is expanding its presence into San Francisco, marking an important step in its U.S. growth strategy. This expansion follows the recent J.P. Morgan Health Conference in San Francisco, highlighting the company’s early success in executing its strategic vision for medical innovation.
HealthTech Insights: Tiny Health Launches Index Predicting Child’s Gut Microbiome Age
As part of this development, Dr. Terrence K. Trapp, an experienced otolaryngologist, has integrated the Company’s MWA system into his practice, suggesting growing interest and recognition of minimally invasive approaches for managing thyroid nodules.
HealthTech Insights: Noom Introduces Free AI-Powered Personalized Health Report to Promote Living Better Longer
Since receiving FDA 510(k) clearance in November 2023, Baird Medical has treated hundreds of patients in the United States with its MWA technology, all of whom have experienced significant recovery and positive treatment outcomes. This growing adoption is exemplified by physicians like Dr. Emad Kandil, Professor of Surgery and Ellis Hanna Chair at Tulane University, who has performed over 100 MWA procedures. His experience further underscores the clinical potential of this technology and the medical community’s increasing recognition of Baird Medical’s innovations.
HealthTech Insights: Scorpius Holdings Announces Collaboration with KaloCyte to Advance Manufacturing for ErythroMer
By collaborating with medical specialists and offering comprehensive training and clinical support, Baird Medical is actively expanding physician education and awareness of MWA technology in the U.S. With its entry into San Francisco, the Company aims to further improve access to minimally invasive treatment options, benefiting both physicians and patients.
To participate in our interviews, please write to our HealthTech Media Room at news@intentamplify.com
Source – prnewswire
